Neuroscience Laboratory, Department of Otorhinolaryngology, University of Jena, Germany.
Neuroscientist. 2012 Oct;18(5):452-66. doi: 10.1177/1073858411419047. Epub 2011 Sep 7.
Understanding restricted functional recovery and designing efficient treatments to alleviate dysfunction after injury of the nervous system remain major challenges in neuroscience and medicine. Numerous molecules of potential significance in neural repair have been identified in vitro, but only few of these have proved to be of major importance in vivo up to now. Among the molecules involved in regeneration are several members of the immunoglobulin superfamily, most notably the neural cell adhesion molecules L1, its close homologue CHL1, and NCAM and, in particular, its polysialic acid glycan moiety. Sufficient evidence is now available to justify the statement that these molecules are major players not only in nervous system development but also in the adult during neural repair and synaptic plasticity. Importantly, insights into the functions of these molecules in promoting or inhibiting functional recovery have allowed the design and assessment of therapeutic approaches in animal models of central nervous system injury that could prove to be applicable in clinical settings.
理解功能受限的恢复,并设计有效的治疗方法来减轻神经系统损伤后的功能障碍,仍然是神经科学和医学的主要挑战。已经在体外鉴定出许多在神经修复中具有潜在意义的分子,但到目前为止,只有少数几种被证明在体内具有重要意义。在参与再生的分子中,有几个免疫球蛋白超家族的成员,其中最重要的是神经细胞粘附分子 L1、其密切同源物 CHL1 和 NCAM,特别是其多涎酸糖基部分。现在已经有足够的证据证明这些分子不仅是神经系统发育过程中的主要参与者,而且在成人的神经修复和突触可塑性过程中也是主要参与者。重要的是,对这些分子在促进或抑制功能恢复中的作用的了解,使得可以在中枢神经系统损伤的动物模型中设计和评估治疗方法,这些方法可能在临床环境中得到应用。